Assessment of V0018 2.5 mg Effect on Craving

NCT02357888 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pierre Fabre Medicament